Nadav Ahituv, assistant professor in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco, discusses the future of genomic sequencing.
He explores the current methods for analyzing the human genome, and describes the potential benefits of knowing exactly how our DNA affects our health.
We are in the midst of a renaissance in the biological sciences, which is spurring the growth of brand new fields like functional and comparative genomics. These new fields are revealing novel insights into evolutionary biology, medicine, developmental biology and many other areas, transforming the way scientists look at life.
Join the California Academy of Sciences to learn about genomics, hear about compelling current research, and explore the future of this rapidly advancing field.
Bio
Nadav Ahituv
Nadav Ahituv is an Assistant Professor in the Department of Bioengineering and Therapeutic Sciences and the Institute for Human Genetics at the University of California, San Francisco.
He received his PhD in human genetics from Tel-Aviv University working on hereditary hearing loss. He then did his postdoc, specializing in human genomics, in the Lawrence Berkeley National Laboratory and the DOE Joint Genome Institute. His current work is focused on discovering gene regulatory elements in the human genome and linking mutations within them to human disease.
Dr. Nadav Ahituv, assistant professor in the Department of Bioengineering and Therapeutic Sciences at UCSF, describes the potential benefits of personalized genomic sequencing.
He argues that DNA information could be used to customize drug treatments in accordance with genetic indicators.